(Q44217519)

30 November 2017

Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. (English)

1 reference

30 November 2017

0 references

1 reference

El-Shabouri MH

1

1 reference

PubMed ID

12433438

30 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

International Journal of Pharmaceutics

30 November 2017

1 reference

30 November 2017

249

1 reference

30 November 2017

1-2

1 reference

30 November 2017

101-108

1 reference

Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Cyclosporine as a new approach to therapy of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Nanospheres of cyclosporin A: poor oral absorption in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Formation and characterization of cyclosporine-loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Chitosan as a novel nasal delivery system for peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Unusual solubility behaviour of cyclosporin A in aqueous media

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Pharmacokinetics and organ distribution of cyclosporin A incorporated in liposomes and mixed micelles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Intestinal absorptive cell tight junctions are linked to cytoskeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Clinical pharmacokinetics of cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Clinical use of cyclosporin in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Submicron cationic emulsions as a new delivery system for oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Cyclosporin metabolism by the gastrointestinal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

Studies on the cyclosporin A loaded stearic acid nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900461-1

7 January 2021

10.1016/S0378-5173(02)00461-1

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12433438